Company intelligence / Profile preview

ChemoMetec

Allerød, Hovedstaden, Denmarkchemometec.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

ChemoMetec’s NucleoCounter® instruments are widely used in biotech, pharma, academic research, and bioprocessing for precise automated cell counting and viability assessment. The company’s products are validated for GMP environments and support applications in immunotherapy, cancer research, stem cells, drug development/production.

Therapeutic areas: Other
Modalities: Device (Automated cell counters and image cytometers)
Industry: Pathology

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed; collaborates with customers across the life sciences sector.

Beyond the preview

Go deeper on ChemoMetec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemoMetec.

Explore the full profile